PRECISION BIOSCIENCES INC
Company Stats
- Market Cap
- $172.8M
- as of Sep 30, 2026
- Shares Outstanding
- 27.6M
- Free Float
- 43.3%
Income Statement
- Revenue
- $34.3M
- Operating Income
- -$52.1M
- Net Income
- -$45.7M
- EBITDA
- -$50.7M
- Non-cash Impairment
- $36,000
- Revenue Growth, 3Y
- 10.9%
- FCF Margin, 3Y Avg
- -151.5%
- FCF Margin, Worst Year
- -192.4%
Cash Flow
- Free Cash Flow
- -$65.9M
- FCF Yield
- -38.2%
- Owner FCF Yield
- -44.1%
Balance Sheet
- Cash & Equivalents
- $110.8M
Returns & Capital
- SBC, 3Y Avg
- $12.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $34.3M | -$65.9M | -192.4% |
| FY2024 | $68.7M | -$58.7M | -85.4% |
| FY2023 | $48.7M | -$86.1M | -176.6% |
| FY2022 | $25.1M | -$49.1M | -195.5% |
| FY2021 | $115.5M | -$15.9M | -13.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges